Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
KSI-501 by Kodiak Sciences for Diabetic Macular Edema: Likelihood of Approval
KSI-501 is under clinical development by Kodiak Sciences and currently in Phase I for Diabetic Macular Edema. According to GlobalData,...
Data Insights
KSI-501 by Kodiak Sciences for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
KSI-501 is under clinical development by Kodiak Sciences and currently in Phase III for Wet (Neovascular / Exudative) Macular Degeneration....